Skip to content

Spinal Manipulation and Patient Self-Management for Preventing Acute to Chronic Back Pain

Spinal Manipulation and Patient Self-Management for Preventing Acute to Chronic Back

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03581123
Acronym
PACBACK
Enrollment
1000
Registered
2018-07-10
Start date
2018-11-01
Completion date
2024-06-12
Last updated
2025-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pain, Low Back Pain, Mechanical

Keywords

acute/subacute low back pain, randomized clinical trial, self-management, behavioral modification, spinal manipulation therapy, standard medical care, secondary prevention

Brief summary

This is a study of adults with acute low back pain flare-up at risk of becoming chronic and disabling. The study tests how well spinal manipulation and guided selfcare work compared to standard medical care. The treatments last up to eight weeks and participants will be followed for one year.

Detailed description

The long-term goal is to reduce overall low back pain (LBP) burden by evaluating, first-line, non-drug treatment strategies that address the biological, psychological and social aspects of acute LBP and prevent transition to chronic back pain. The study will also assess barriers and facilitators that impact future implementation of the non-drug treatments into clinical practice. The US faces an unprecedented pain management crisis. LBP is the most common chronic pain condition in adults and one of the leading causes of disability worldwide. Guidelines have recommended non-drug treatments like spinal manipulation and behavioral and selfcare approaches for LBP for nearly a decade, yet uptake and adherence has been poor. Little is known about the role of these treatments in the secondary prevention of chronic LBP, especially for patients at risk of developing severe low back pain. Due to high societal costs, and side effects of commonly used drug treatments, including opioids, there is a critical need for research on how well non-drug treatments work for preventing serious chronic LBP.

Interventions

BEHAVIORALSupported-Self Management (SSM)

Provides low back pain sufferers opportunities to develop the capacity and motivation to self-manage their pain in an adaptive manner. This includes psychological/behavioral strategies, mind-body approaches, lifestyle advice, pain education and pain coping.

SMT will address the biological and physical aspects of low back pain (e.g. spinal dysfunction) with the intention of restoring maximum movement and functional ability of the spine.

COMBINATION_PRODUCTSMT + SSM

Combination Treatment

Guideline based medical care informed by the American College of Physicians' guidelines on noninvasive treatment for low back pain.

Sponsors

University of Pittsburgh
CollaboratorOTHER
University of Washington
CollaboratorOTHER
University of North Texas Health Science Center
CollaboratorOTHER
Oregon Health and Science University
CollaboratorOTHER
Duke University
CollaboratorOTHER
University of Minnesota
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Intervention model description

2x2 factorial design

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* At least 18 years of age * Acute or sub-acute low back pain * Average low back pain severity ≥3 on the 0-10 numerical rating scale over 7 days * Medium or high risk for persistent disabling back pain according to the STarT Back screening tool * Ability to read and write fluently in English

Exclusion criteria

* Non-mechanical causes of low back pain * Contraindications to study treatments (e.g,. surgical fusion of lumbar spine) * Active management of current episode of low back pain by another healthcare provider * Serious co-morbid health condition that either requires medical attention or has a risk for general health decline over the next year * Pregnancy, current or planned during study period and nursing mothers * Inability or unwillingness to give written informed consent

Design outcomes

Primary

MeasureTime frameDescription
DisabilityAverage over months 1-12Measured using the Roland-Morris Disability Questionnaire (RMDQ), a 24-item questionnaire that measures the degree to which a low back problem restricts daily activities. Score ranges from 0 to 24 with higher values indicating more disability. Missing monthly outcomes were multiply imputed. Means were estimated using marginal standardization with adjustment for site, time period, risk of chronicity, and baseline RMDQ.
Pain IntensityAverage over weeks 1-52Measured using the 0-10 numerical rating scale (0=no LBP, 10=the worst LBP possible). Missing weekly outcomes were multiply imputed. Means were estimated using marginal standardization with adjustment for site, time period, risk of chronicity, and baseline pain intensity.
Low Back Pain (LBP) That is ImpactfulAverage over months 10 -12Measured by the LBP impact scale, which includes measures of pain intensity, pain interference, and physical function from the PROMIS-29 Profile v2.0. The scale ranges from 8 (least impact) to 50 (greatest impact). Missing monthly outcomes were multiply imputed. Means were estimated using marginal standardization with adjustment for site, time period, risk of chronicity, and baseline LBP impact score.

Secondary

MeasureTime frameDescription
Number of Participants Who Received Care For Low Back PainMonths 1-12Includes provider visits, emergency department visits, diagnostic imaging scans, hospitalizations, injections and surgical procedures. This is a binary indicator of any care from providers outside the study for low back pain.
Medication Use - Percent of Months 4-12Months 4-12Over the counter and prescription medication use for low back pain. Since the MC arm intervention includes medications, only months 4-12 (i.e. after the intervention) are considered for this outcome. The measure is the percent of months 4-12 in which medication was used for low back pain. Mean and confidence intervals are estimated using marginal standardization and bootstrapping. Adjustment for site, time period, and risk for chronicity.
Bothered by Low Back Pain at Work - Percent of MonthsMonths 1-12Participants indicated in monthly follow-ups if they were bothered by low back pain over the last month. This measure is the percent of months that participants were bothered by low back pain at work. Mean and confidence intervals are estimated using marginal standardization and bootstrapping. Adjustment for site, time period, and risk for chronicity.
Global Improvement2 monthsMeasured using a 9-point scale: 0 (vastly worse) to 8 (completely recovered )
Patient Satisfaction With Treatment2 monthsMeasured using a 7-point Likert scale: 0 (completely dissatisfied) to 6 (completely satisfied)
Chronic Low Back Pain (LBP)6 monthsMeasured by the proportion of patients in each group meeting the definition by the NIH Task Force on Research Standards for Chronic LBP (i.e., ongoing LBP on ≥50% of days over past 6 months).
Number of Participants Who Reported Chronic Interference With Daily Activities6 monthsAssessed using how often has low back pain interfered with your ability to do regular activities over the past 6 months? on a 3-item scale (less than half the days in the past 6 months, at least half the days in the past 6 months, every day or nearly every day in the past 6 months). Here we dichotomize to at least half the days in the past 6 months or more.
Timed Up and Go Test2 monthsMeasured by a blinded examiner, in seconds, the time taken by a person to stand up, walk a distance of 10 feet, turn, walk back to the chair and sit down again.
Sit-to-stand2 monthsMeasured by a blinded examiner, in seconds, the amount of time a person requires to stand up and sit down from a chair 5 times without using their arms
Recovery From Acute/Sub-acute Low Back Pain6 monthsMeasured by the proportion of patients with scores of 0 on the 0-10 pain numeric rating scale (NRS) and a score of less than or equal to 2 on the Roland-Morris Disability Questionnaire (RMDQ), a 24-item questionnaire that measures the degree to which a low back problem restricts daily activities.
Low Back Pain Frequency - Percent of Days Over 12 MonthsWeeks 1-52Participants report the number of days that low back pain has been a problem in the past 7 days for 52 weeks. This measure is the percent of days that low back pain has been a problem. Mean and confidence intervals are estimated using marginal standardization and bootstrapping. Adjustment for site, time period, and risk for chronicity.
Patient-Reported Outcomes Measurement Information System (PROMIS) - Sleep DisturbanceBaseline and 2, 6, and 12 monthsThe PROMIS sleep disturbance scale consists of 4 questions related to sleep disturbance over the past 7 days. The raw score is converted to the T-Score that is reported here. The range of possible scores is 32.0 - 73.3. Higher scores indicate greater sleep disturbance. A score of 50 represents the average score in a general US reference population and 10 is the standard deviation.
Patient-Reported Outcomes Measurement Information System (PROMIS) - ParticipationBaseline and 2, 6, and 12 monthsThe PROMIS participation scale consists of 4 questions related to participation in social activities. The raw score is converted to the T-Score that is reported here. The range of possible scores is 27.5 - 64.2. Higher scores indicate greater ability to participate in social activities. A score of 50 represents the average score in a general US reference population and 10 is the standard deviation.
Patient-Reported Outcomes Measurement Information System (PROMIS) - Pain InterferenceBaseline and 2, 6, and 12 monthsThe PROMIS participation scale consists of 4 questions related to pain interference in the last 7 days. The raw score is converted to the T-Score that is reported here. The range of possible scores is 41.6 - 75.6. Higher scores indicate greater pain interference. A score of 50 represents the average score in a general US reference population and 10 is the standard deviation.
STarT Back Risk Classification2 monthsThe STarT Back Screening Tool is a 9-item questionnaire used to identify prognostic risk factors in patients with low back pain. It assesses physical and psychosocial factors, including referred pain, disability, fear-avoidance, anxiety, and depression. Scores are totaled (0-9) and a psychosocial subscale score (items 5-9, range 0-5) is calculated. Patients are classified as: low risk (total ≤3), medium risk (total ≥4 and psychosocial subscale ≤3), or high risk (total ≥4 and psychosocial subscale ≥4).
The Sock Test2 monthsMeasured by a blinded examiner on a scale from 0-3, with 0 being can easily grab the toes with the fingertips of both hands and 3 being can hardly, if at all, reach as far as to the malleoli. Each leg is scored separately with the greater leg score serving as the overall score.
Visual Trajectory for Pain12 monthsAssessed using 8 different diagrams describing back pain change over the last 12 months
Quebec Task Force2 monthsMeasured by a blinded examiner who will classify the participant's spinal disorder as 0) no pain; 1) pain without radiation; 2) pain with radiation to the proximal extremity; 3) pain with radiation to the distal extremity; 4) pain with radiation to the extremity and neurologic signs.
Patient-Reported Outcomes Measurement Information System (PROMIS) - DepressionBaseline and 2, 6, and 12 monthsThe PROMIS depression scale consists of 4 questions related to depression over the past 7 days. The raw score is converted to the T-Score that is reported here. The range of possible scores is 41.0 - 79.3. Higher scores indicate greater depression. A score of 50 represents the average score in a general US reference population and 10 is the standard deviation.
Patient-Reported Outcomes Measurement Information System (PROMIS) - Physical FunctionBaseline and 2, 6, and 12 monthsThe PROMIS physical function scale consists of 4 questions about ability to perform tasks of daily living. The raw score is converted to the T-Score that is reported here. The range of possible scores is 22.6 - 57.0. Higher scores indicate greater physical function. A score of 50 represents the average score in a general US reference population and 10 is the standard deviation.
Patient-Reported Outcomes Measurement Information System (PROMIS) - AnxietyBaseline and 2, 6, and 12 monthsThe PROMIS anxiety scale consists of 4 questions related to anxiety over the past 7 days. The raw score is converted to the T-Score that is reported here. The range of possible scores is 40.3 - 81.4. Higher scores indicate greater anxiety. A score of 50 represents the average score in a general US reference population and 10 is the standard deviation.
Patient-Reported Outcomes Measurement Information System (PROMIS) - FatigueBaseline and 2, 6, and 12 monthsThe PROMIS fatigue scale consists of 4 questions related to fatigue over the past 7 days. The raw score is converted to the T-Score that is reported here. The range of possible scores is 33.7 - 75.8. Higher scores indicate greater fatigue. A score of 50 represents the average score in a general US reference population and 10 is the standard deviation.

Other

MeasureTime frameDescription
Self-efficacyBaseline, 2, 6, 12 monthsUsing a 10-100 numerical rating scale (10=very uncertain, 100 = very certain), self-efficacy is measured with the 22-item Chronic Pain Self-Efficacy Scale adapted for acute/sub-acute pain. This is a psychosocial mediating measure.
KinesiophobiaBaseline, 2, 6, 12 monthsMeasured using the 11-item Tampa Scale for Kinesiophobia demonstrated to have internal consistency, responsiveness and validity similar to the original 17-item instrument. A four-item scale is used (strongly disagree to strongly agree). This is a psychosocial mediating measure.
CatastrophizingBaseline, 2, 6, 12 monthsMeasured using the 13-item Pain Catastrophizing Scale; it uses a 5-item point scale (0=not at all, 4 all the time). This is a psychosocial mediating measure.
CopingBaseline, 2, 6, 12 monthsMeasured using an adapted version of the 28-item Brief Coping Orientation to Problems Experienced (COPE) instrument on a 4 point scale (I haven't been doing this at all to I've been doing this a lot). This is a psychosocial mediating measure.

Countries

United States

Participant flow

Participants by arm

ArmCount
Supported Self-Management (SSM)
Supported Self-Management (SSM): Provides low back pain sufferers opportunities to develop the capacity and motivation to self-manage their pain in an adaptive manner. This includes psychological/behavioral strategies, mind-body approaches, lifestyle advice, pain education and pain coping.
305
Spinal Manipulation Therapy (SMT)
Spinal manipulation therapy (SMT): Addresses the biological and physical aspects of low back pain (e.g. spinal dysfunction) with the intention of restoring maximum movement and functional ability of the spine.
201
Combined SSM/SMT
Supported self-management / spinal manipulation therapy (SSM/SMT): Combination treatment.
193
Medical Care (MC)
Medical care (MC): Guideline based medical care informed by the American College of Physicians' guidelines on noninvasive treatment for low back pain.
301
Total1,000

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
12-Month Follow-upLost to Follow-up4345
2-month Follow-upLost to Follow-up8122
2-month Follow-upWithdrawal by Subject5464
6-Month Follow-upLost to Follow-up3311
6-Month Follow-upWithdrawal by Subject2012

Baseline characteristics

CharacteristicSupported Self-Management (SSM)TotalMedical Care (MC)Combined SSM/SMTSpinal Manipulation Therapy (SMT)
Age, Continuous47 Years
STANDARD_DEVIATION 15
47 Years
STANDARD_DEVIATION 16
47 Years
STANDARD_DEVIATION 16
47 Years
STANDARD_DEVIATION 17
48 Years
STANDARD_DEVIATION 16
Disability11.6 score on a scale
STANDARD_DEVIATION 4.9
11.2 score on a scale
STANDARD_DEVIATION 4.7
11.4 score on a scale
STANDARD_DEVIATION 4.5
10.8 score on a scale
STANDARD_DEVIATION 4.8
10.9 score on a scale
STANDARD_DEVIATION 4.6
Ethnicity (NIH/OMB)
Hispanic or Latino
7 Participants46 Participants18 Participants12 Participants9 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
297 Participants949 Participants283 Participants178 Participants191 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants5 Participants0 Participants3 Participants1 Participants
Low Back Pain Impact Score25.9 score on a scale
STANDARD_DEVIATION 6.7
25.6 score on a scale
STANDARD_DEVIATION 6.7
26.1 score on a scale
STANDARD_DEVIATION 6.7
25.2 score on a scale
STANDARD_DEVIATION 6.5
24.6 score on a scale
STANDARD_DEVIATION 6.6
Pain intensity5.5 score on a scale
STANDARD_DEVIATION 1.6
5.4 score on a scale
STANDARD_DEVIATION 1.6
5.4 score on a scale
STANDARD_DEVIATION 1.6
5.4 score on a scale
STANDARD_DEVIATION 1.6
5.4 score on a scale
STANDARD_DEVIATION 1.5
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants2 Participants1 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
17 Participants59 Participants18 Participants13 Participants11 Participants
Race (NIH/OMB)
Black or African American
25 Participants66 Participants18 Participants16 Participants7 Participants
Race (NIH/OMB)
More than one race
3 Participants28 Participants10 Participants8 Participants7 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants10 Participants3 Participants2 Participants4 Participants
Race (NIH/OMB)
White
258 Participants835 Participants251 Participants154 Participants172 Participants
Recruitment Time Period
COVID
106 Participants211 Participants105 Participants0 Participants0 Participants
Recruitment Time Period
Post-COVID
153 Participants603 Participants151 Participants145 Participants154 Participants
Recruitment Time Period
Pre-COVID
46 Participants186 Participants45 Participants48 Participants47 Participants
Sex/Gender, Customized
Gender
Female
175 Participants577 Participants181 Participants117 Participants104 Participants
Sex/Gender, Customized
Gender
Male
124 Participants410 Participants117 Participants74 Participants95 Participants
Sex/Gender, Customized
Gender
Other
5 Participants12 Participants3 Participants2 Participants2 Participants
Sex/Gender, Customized
Gender
Unknown/not reported
1 Participants1 Participants0 Participants0 Participants0 Participants
Site
Minneapolis
185 Participants582 Participants182 Participants105 Participants110 Participants
Site
Pittsburgh
120 Participants418 Participants119 Participants88 Participants91 Participants
STarT Back Risk Category
High
93 Participants301 Participants99 Participants58 Participants51 Participants
STarT Back Risk Category
Medium
212 Participants699 Participants202 Participants135 Participants150 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 2980 / 1980 / 1900 / 296
other
Total, other adverse events
93 / 29863 / 19863 / 19082 / 296
serious
Total, serious adverse events
27 / 29813 / 19822 / 19022 / 296

Outcome results

Primary

Disability

Measured using the Roland-Morris Disability Questionnaire (RMDQ), a 24-item questionnaire that measures the degree to which a low back problem restricts daily activities. Score ranges from 0 to 24 with higher values indicating more disability. Missing monthly outcomes were multiply imputed. Means were estimated using marginal standardization with adjustment for site, time period, risk of chronicity, and baseline RMDQ.

Time frame: Average over months 1-12

ArmMeasureValue (MEAN)Dispersion
Supported Self-Management (SSM)Disability4.7 score on a scaleStandard Error 0.2
Spinal Manipulation Therapy (SMT)Disability5.5 score on a scaleStandard Error 0.3
Combined SSM/SMTDisability4.8 score on a scaleStandard Error 0.3
Medical Care (MC)Disability5.9 score on a scaleStandard Error 0.2
Comparison: The null hypothesis here is that the means are equal across the 4 treatment groups. A significant p value indicates rejection of the null.p-value: 0.001ANOVA
Comparison: Adjusted for site, time period, risk of chronicity, and baseline RMDQ.95% CI: [-1.9, -0.5]
Comparison: Adjusted for site, time period, risk of chronicity, and baseline RMDQ.95% CI: [-1.2, 0.4]
Comparison: Adjusted for site, time period, risk of chronicity, and baseline RMDQ.95% CI: [-1.9, -0.3]
Primary

Low Back Pain (LBP) That is Impactful

Measured by the LBP impact scale, which includes measures of pain intensity, pain interference, and physical function from the PROMIS-29 Profile v2.0. The scale ranges from 8 (least impact) to 50 (greatest impact). Missing monthly outcomes were multiply imputed. Means were estimated using marginal standardization with adjustment for site, time period, risk of chronicity, and baseline LBP impact score.

Time frame: Average over months 10 -12

ArmMeasureValue (MEAN)Dispersion
Supported Self-Management (SSM)Low Back Pain (LBP) That is Impactful15.3 score on a scaleStandard Error 0.4
Spinal Manipulation Therapy (SMT)Low Back Pain (LBP) That is Impactful16.7 score on a scaleStandard Error 0.5
Combined SSM/SMTLow Back Pain (LBP) That is Impactful15.7 score on a scaleStandard Error 0.5
Medical Care (MC)Low Back Pain (LBP) That is Impactful17.0 score on a scaleStandard Error 0.4
Comparison: The null hypothesis here is that the means are equal across the 4 treatment groups. A significant p value indicates rejection of the null.p-value: 0.006ANOVA
Comparison: Adjusted for site, time period, risk of chronicity, and baseline LBP impact score.95% CI: [-2.7, -0.6]
Comparison: Adjusted for site, time period, risk of chronicity, and baseline LBP impact score.95% CI: [-1.5, 1]
Comparison: Adjusted for site, time period, risk of chronicity, and baseline LBP impact score.95% CI: [-2.5, 0]
Primary

Pain Intensity

Measured using the 0-10 numerical rating scale (0=no LBP, 10=the worst LBP possible). Missing weekly outcomes were multiply imputed. Means were estimated using marginal standardization with adjustment for site, time period, risk of chronicity, and baseline pain intensity.

Time frame: Average over weeks 1-52

ArmMeasureValue (MEAN)Dispersion
Supported Self-Management (SSM)Pain Intensity2.8 score on a scaleStandard Error 0.1
Spinal Manipulation Therapy (SMT)Pain Intensity3.0 score on a scaleStandard Error 0.1
Combined SSM/SMTPain Intensity2.8 score on a scaleStandard Error 0.1
Medical Care (MC)Pain Intensity3.0 score on a scaleStandard Error 0.1
Comparison: The null hypothesis here is that the means are equal across the 4 treatment groups. A significant p value indicates rejection of the null.p-value: 0.16ANOVA
Comparison: Adjusted for site, time period, risk of chronicity, and baseline pain intensity.95% CI: [-0.5, 0]
Comparison: Adjusted for site, time period, risk of chronicity, and baseline pain intensity.95% CI: [-0.3, 0.3]
Comparison: Adjusted for site, time period, risk of chronicity, and baseline pain intensity.95% CI: [-0.4, 0.1]
Secondary

Bothered by Low Back Pain at Work - Percent of Months

Participants indicated in monthly follow-ups if they were bothered by low back pain over the last month. This measure is the percent of months that participants were bothered by low back pain at work. Mean and confidence intervals are estimated using marginal standardization and bootstrapping. Adjustment for site, time period, and risk for chronicity.

Time frame: Months 1-12

Population: Only participants with at least 8 months of follow-up between months 1 and 12 are included in the analysis.

ArmMeasureValue (MEAN)
Supported Self-Management (SSM)Bothered by Low Back Pain at Work - Percent of Months43 Percent of months
Spinal Manipulation Therapy (SMT)Bothered by Low Back Pain at Work - Percent of Months45 Percent of months
Combined SSM/SMTBothered by Low Back Pain at Work - Percent of Months43 Percent of months
Medical Care (MC)Bothered by Low Back Pain at Work - Percent of Months51 Percent of months
Comparison: Adjusted for site, time period, and risk of chronicity.95% CI: [-13, -3]
Comparison: Adjusted for site, time period, and risk of chronicity.95% CI: [-12, 1]
Comparison: Adjusted for site, time period, and risk of chronicity.95% CI: [-15, -1]
Secondary

Chronic Low Back Pain (LBP)

Measured by the proportion of patients in each group meeting the definition by the NIH Task Force on Research Standards for Chronic LBP (i.e., ongoing LBP on ≥50% of days over past 6 months).

Time frame: 6 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Supported Self-Management (SSM)Chronic Low Back Pain (LBP)119 Participants
Spinal Manipulation Therapy (SMT)Chronic Low Back Pain (LBP)81 Participants
Combined SSM/SMTChronic Low Back Pain (LBP)78 Participants
Medical Care (MC)Chronic Low Back Pain (LBP)154 Participants
Comparison: Adjusted for site, time period, and risk of chronicity.95% CI: [-21, -4]
Comparison: Adjusted for site, time period, and risk of chronicity.95% CI: [-22, -3]
Comparison: Adjusted for site, time period, and risk of chronicity.95% CI: [-22, -3]
Secondary

Chronic Low Back Pain (LBP)

Measured by the proportion of patients in each group meeting the definition by the NIH Task Force on Research Standards for Chronic LBP (i.e., ongoing LBP on ≥50% of days over past 6 months).

Time frame: 12 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Supported Self-Management (SSM)Chronic Low Back Pain (LBP)93 Participants
Spinal Manipulation Therapy (SMT)Chronic Low Back Pain (LBP)93 Participants
Combined SSM/SMTChronic Low Back Pain (LBP)68 Participants
Medical Care (MC)Chronic Low Back Pain (LBP)151 Participants
Comparison: Adjusted for site, time period, and risk of chronicity.95% CI: [-28, -12]
Comparison: Adjusted for site, time period, and risk of chronicity.95% CI: [-13, 6]
Comparison: Adjusted for site, time period, and risk of chronicity.95% CI: [-26, -7]
Secondary

Global Improvement

Measured using a 9-point scale: 0 (vastly worse) to 8 (completely recovered )

Time frame: 12 months

Population: The Participant Flow tables show counts of completed follow-up defined by completion of the Roland-Morris Disability Questionnaire (RMDQ). There are some participants who completed the RMDQ but not this measure and vice versa. Thus the analysis counts for each time point here may differ somewhat from the Participant Flow tables.

ArmMeasureValue (MEAN)Dispersion
Supported Self-Management (SSM)Global Improvement6.2 score on a scaleStandard Deviation 1.3
Spinal Manipulation Therapy (SMT)Global Improvement5.8 score on a scaleStandard Deviation 1.6
Combined SSM/SMTGlobal Improvement6.3 score on a scaleStandard Deviation 1.4
Medical Care (MC)Global Improvement5.5 score on a scaleStandard Deviation 1.6
Secondary

Global Improvement

Measured using a 9-point scale: 0 (vastly worse) to 8 (completely recovered )

Time frame: 2 months

Population: The Participant Flow tables show counts of completed follow-up defined by completion of the Roland-Morris Disability Questionnaire (RMDQ). There are some participants who completed the RMDQ but not this measure and vice versa. Thus the analysis counts for each time point here may differ somewhat from the Participant Flow tables.

ArmMeasureValue (MEAN)Dispersion
Supported Self-Management (SSM)Global Improvement6.2 score on a scaleStandard Deviation 1.2
Spinal Manipulation Therapy (SMT)Global Improvement6.3 score on a scaleStandard Deviation 1
Combined SSM/SMTGlobal Improvement6.4 score on a scaleStandard Deviation 1.1
Medical Care (MC)Global Improvement5.7 score on a scaleStandard Deviation 1.5
Secondary

Global Improvement

Measured using a 9-point scale: 0 (vastly worse) to 8 (completely recovered )

Time frame: 6 months

Population: The Participant Flow tables show counts of completed follow-up defined by completion of the Roland-Morris Disability Questionnaire (RMDQ). There are some participants who completed the RMDQ but not this measure and vice versa. Thus the analysis counts for each time point here may differ somewhat from the Participant Flow tables.

ArmMeasureValue (MEAN)Dispersion
Supported Self-Management (SSM)Global Improvement6.1 score on a scaleStandard Deviation 1.4
Spinal Manipulation Therapy (SMT)Global Improvement6.0 score on a scaleStandard Deviation 1.3
Combined SSM/SMTGlobal Improvement6.3 score on a scaleStandard Deviation 1.4
Medical Care (MC)Global Improvement5.5 score on a scaleStandard Deviation 1.7
Secondary

Low Back Pain Frequency - Percent of Days Over 12 Months

Participants report the number of days that low back pain has been a problem in the past 7 days for 52 weeks. This measure is the percent of days that low back pain has been a problem. Mean and confidence intervals are estimated using marginal standardization and bootstrapping. Adjustment for site, time period, and risk for chronicity.

Time frame: Weeks 1-52

Population: Only participants with at least 35 weeks of follow-up between weeks 1 and 52 are included in the analysis.

ArmMeasureValue (MEAN)
Supported Self-Management (SSM)Low Back Pain Frequency - Percent of Days Over 12 Months39 Percent of days
Spinal Manipulation Therapy (SMT)Low Back Pain Frequency - Percent of Days Over 12 Months44 Percent of days
Combined SSM/SMTLow Back Pain Frequency - Percent of Days Over 12 Months38 Percent of days
Medical Care (MC)Low Back Pain Frequency - Percent of Days Over 12 Months46 Percent of days
Comparison: Adjusted for site, time period, and risk of chronicity.95% CI: [-11, -1]
Comparison: Adjusted for site, time period, and risk of chronicity.95% CI: [-7, 5]
Comparison: Adjusted for site, time period, and risk of chronicity.95% CI: [-13, 2]
Secondary

Medication Use - Percent of Months 4-12

Over the counter and prescription medication use for low back pain. Since the MC arm intervention includes medications, only months 4-12 (i.e. after the intervention) are considered for this outcome. The measure is the percent of months 4-12 in which medication was used for low back pain. Mean and confidence intervals are estimated using marginal standardization and bootstrapping. Adjustment for site, time period, and risk for chronicity.

Time frame: Months 4-12

Population: Only participants with at least 6 months of follow-up between months 4 and 12 are included in the analysis.

ArmMeasureValue (MEAN)
Supported Self-Management (SSM)Medication Use - Percent of Months 4-1237 Percent of months 4-12
Spinal Manipulation Therapy (SMT)Medication Use - Percent of Months 4-1240 Percent of months 4-12
Combined SSM/SMTMedication Use - Percent of Months 4-1237 Percent of months 4-12
Medical Care (MC)Medication Use - Percent of Months 4-1254 Percent of months 4-12
Comparison: Adjusted for site, time period, and risk of chronicity.95% CI: [-23, -10]
Comparison: Adjusted for site, time period, and risk of chronicity.95% CI: [-22, -7]
Comparison: Adjusted for site, time period, and risk of chronicity.95% CI: [-24, -9]
Secondary

Number of Participants Who Received Care For Low Back Pain

Includes provider visits, emergency department visits, diagnostic imaging scans, hospitalizations, injections and surgical procedures. This is a binary indicator of any care from providers outside the study for low back pain.

Time frame: Months 1-12

Population: Only participants with at least 8 months of follow-up between months 1 and 12 on this outcome are included in the analysis.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Supported Self-Management (SSM)Number of Participants Who Received Care For Low Back Pain82 Participants
Spinal Manipulation Therapy (SMT)Number of Participants Who Received Care For Low Back Pain67 Participants
Combined SSM/SMTNumber of Participants Who Received Care For Low Back Pain53 Participants
Medical Care (MC)Number of Participants Who Received Care For Low Back Pain128 Participants
Comparison: Adjusted for site, time period, and risk of chronicity.95% CI: [-23, -7]
Comparison: Adjusted for site, time period, and risk of chronicity.95% CI: [-20, 2]
Comparison: Adjusted for site, time period, and risk of chronicity.95% CI: [-27, -9]
Secondary

Number of Participants Who Reported Chronic Interference With Daily Activities

Assessed using how often has low back pain interfered with your ability to do regular activities over the past 6 months? on a 3-item scale (less than half the days in the past 6 months, at least half the days in the past 6 months, every day or nearly every day in the past 6 months). Here we dichotomize to at least half the days in the past 6 months or more.

Time frame: 12 months

Population: The Participant Flow tables show counts of completed follow-up defined by completion of the Roland-Morris Disability Questionnaire (RMDQ). There are some participants who completed the RMDQ but not this measure and vice versa. Thus the analysis counts for each time point here may differ somewhat from the Participant Flow tables.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Supported Self-Management (SSM)Number of Participants Who Reported Chronic Interference With Daily Activities41 Participants
Spinal Manipulation Therapy (SMT)Number of Participants Who Reported Chronic Interference With Daily Activities36 Participants
Combined SSM/SMTNumber of Participants Who Reported Chronic Interference With Daily Activities36 Participants
Medical Care (MC)Number of Participants Who Reported Chronic Interference With Daily Activities76 Participants
Comparison: Adjusted for site, time period, and risk of chronicity.95% CI: [-19, -5]
Comparison: Adjusted for site, time period, and risk of chronicity.95% CI: [-16, -1]
Comparison: Adjusted for site, time period, and risk of chronicity.95% CI: [-16, 1]
Secondary

Number of Participants Who Reported Chronic Interference With Daily Activities

Assessed using how often has low back pain interfered with your ability to do regular activities over the past 6 months? on a 3-item scale (less than half the days in the past 6 months, at least half the days in the past 6 months, every day or nearly every day in the past 6 months). Here we dichotomize to at least half the days in the past 6 months or more.

Time frame: 6 months

Population: The Participant Flow tables show counts of completed follow-up defined by completion of the Roland-Morris Disability Questionnaire (RMDQ). There are some participants who completed the RMDQ but not this measure and vice versa. Thus the analysis counts for each time point here may differ somewhat from the Participant Flow tables.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Supported Self-Management (SSM)Number of Participants Who Reported Chronic Interference With Daily Activities57 Participants
Spinal Manipulation Therapy (SMT)Number of Participants Who Reported Chronic Interference With Daily Activities41 Participants
Combined SSM/SMTNumber of Participants Who Reported Chronic Interference With Daily Activities38 Participants
Medical Care (MC)Number of Participants Who Reported Chronic Interference With Daily Activities80 Participants
Comparison: Adjusted for site, time period, and risk of chronicity.95% CI: [-15, -1]
Comparison: Adjusted for site, time period, and risk of chronicity.95% CI: [-22, -3]
Comparison: Adjusted for site, time period, and risk of chronicity.95% CI: [-22, -3]
Secondary

Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety

The PROMIS anxiety scale consists of 4 questions related to anxiety over the past 7 days. The raw score is converted to the T-Score that is reported here. The range of possible scores is 40.3 - 81.4. Higher scores indicate greater anxiety. A score of 50 represents the average score in a general US reference population and 10 is the standard deviation.

Time frame: Baseline and 2, 6, and 12 months

Population: The Participant Flow tables show counts of completed follow-up defined by completion of the Roland-Morris Disability Questionnaire (RMDQ). There are some participants who completed the RMDQ but not this measure and vice versa. Thus the analysis counts for each time point here may differ somewhat from the Participant Flow tables.

ArmMeasureGroupValue (MEAN)Dispersion
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety2-month51.7 T-ScoreStandard Deviation 8
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety6-month49.4 T-ScoreStandard Deviation 8.9
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety12-month48.9 T-ScoreStandard Deviation 9.1
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - AnxietyBaseline53.5 T-ScoreStandard Deviation 8.2
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety2-month51.2 T-ScoreStandard Deviation 8.2
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - AnxietyBaseline53.6 T-ScoreStandard Deviation 7.9
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety6-month49.2 T-ScoreStandard Deviation 9.2
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety12-month48.7 T-ScoreStandard Deviation 8.9
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - AnxietyBaseline54.2 T-ScoreStandard Deviation 7.6
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety2-month52.6 T-ScoreStandard Deviation 8.3
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety6-month50.6 T-ScoreStandard Deviation 9.7
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety12-month49.1 T-ScoreStandard Deviation 9.5
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety6-month50.3 T-ScoreStandard Deviation 9.5
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety2-month52.6 T-ScoreStandard Deviation 8.5
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - AnxietyBaseline53.8 T-ScoreStandard Deviation 8.3
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety12-month50.1 T-ScoreStandard Deviation 9.8
Secondary

Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression

The PROMIS depression scale consists of 4 questions related to depression over the past 7 days. The raw score is converted to the T-Score that is reported here. The range of possible scores is 41.0 - 79.3. Higher scores indicate greater depression. A score of 50 represents the average score in a general US reference population and 10 is the standard deviation.

Time frame: Baseline and 2, 6, and 12 months

Population: The Participant Flow tables show counts of completed follow-up defined by completion of the Roland-Morris Disability Questionnaire (RMDQ). There are some participants who completed the RMDQ but not this measure and vice versa. Thus the analysis counts for each time point here may differ somewhat from the Participant Flow tables.

ArmMeasureGroupValue (MEAN)Dispersion
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression6-month48.2 T-ScoreStandard Deviation 8.1
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression2-month49.6 T-ScoreStandard Deviation 7.6
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - DepressionBaseline50.6 T-ScoreStandard Deviation 7.2
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression12-month48.2 T-ScoreStandard Deviation 8
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression2-month49.0 T-ScoreStandard Deviation 7.9
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - DepressionBaseline50.2 T-ScoreStandard Deviation 7.4
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression6-month48.2 T-ScoreStandard Deviation 7.8
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression12-month47.8 T-ScoreStandard Deviation 8.2
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - DepressionBaseline50.8 T-ScoreStandard Deviation 7.3
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - Depression6-month48.6 T-ScoreStandard Deviation 8.4
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - Depression2-month49.7 T-ScoreStandard Deviation 8.2
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - Depression12-month48.2 T-ScoreStandard Deviation 8.2
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression2-month50.4 T-ScoreStandard Deviation 8
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression6-month49.6 T-ScoreStandard Deviation 8.5
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression12-month49.0 T-ScoreStandard Deviation 8.9
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - DepressionBaseline50.8 T-ScoreStandard Deviation 8.3
Secondary

Patient-Reported Outcomes Measurement Information System (PROMIS) - Fatigue

The PROMIS fatigue scale consists of 4 questions related to fatigue over the past 7 days. The raw score is converted to the T-Score that is reported here. The range of possible scores is 33.7 - 75.8. Higher scores indicate greater fatigue. A score of 50 represents the average score in a general US reference population and 10 is the standard deviation.

Time frame: Baseline and 2, 6, and 12 months

Population: The Participant Flow tables show counts of completed follow-up defined by completion of the Roland-Morris Disability Questionnaire (RMDQ). There are some participants who completed the RMDQ but not this measure and vice versa. Thus the analysis counts for each time point here may differ somewhat from the Participant Flow tables.

ArmMeasureGroupValue (MEAN)Dispersion
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - Fatigue6-month51.3 T-ScoreStandard Deviation 9.7
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - FatigueBaseline55.2 T-ScoreStandard Deviation 8.1
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - Fatigue12-month50.8 T-ScoreStandard Deviation 10.1
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - Fatigue2-month52.4 T-ScoreStandard Deviation 8.5
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - Fatigue12-month50.6 T-ScoreStandard Deviation 10.1
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - Fatigue6-month50.8 T-ScoreStandard Deviation 9.7
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - Fatigue2-month51.2 T-ScoreStandard Deviation 8
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - FatigueBaseline54.3 T-ScoreStandard Deviation 8.1
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - FatigueBaseline54.8 T-ScoreStandard Deviation 8
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - Fatigue6-month50.4 T-ScoreStandard Deviation 10.1
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - Fatigue2-month51.8 T-ScoreStandard Deviation 8.4
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - Fatigue12-month50.0 T-ScoreStandard Deviation 10.2
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - Fatigue2-month53.8 T-ScoreStandard Deviation 9.2
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - FatigueBaseline55.2 T-ScoreStandard Deviation 8.5
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - Fatigue12-month52.3 T-ScoreStandard Deviation 10.1
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - Fatigue6-month52.2 T-ScoreStandard Deviation 10.5
Secondary

Patient-Reported Outcomes Measurement Information System (PROMIS) - Pain Interference

The PROMIS participation scale consists of 4 questions related to pain interference in the last 7 days. The raw score is converted to the T-Score that is reported here. The range of possible scores is 41.6 - 75.6. Higher scores indicate greater pain interference. A score of 50 represents the average score in a general US reference population and 10 is the standard deviation.

Time frame: Baseline and 2, 6, and 12 months

Population: The Participant Flow tables show counts of completed follow-up defined by completion of the Roland-Morris Disability Questionnaire (RMDQ). There are some participants who completed the RMDQ but not this measure and vice versa. Thus the analysis counts for each time point here may differ somewhat from the Participant Flow tables.

ArmMeasureGroupValue (MEAN)Dispersion
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - Pain Interference6-month51.4 T-ScoreStandard Deviation 7.9
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - Pain InterferenceBaseline60.3 T-ScoreStandard Deviation 5
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - Pain Interference2-month52.9 T-ScoreStandard Deviation 7
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - Pain Interference12-month50.3 T-ScoreStandard Deviation 8.4
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - Pain Interference2-month52.0 T-ScoreStandard Deviation 7.3
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - Pain Interference6-month51.5 T-ScoreStandard Deviation 7.6
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - Pain InterferenceBaseline59.2 T-ScoreStandard Deviation 5.4
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - Pain Interference12-month51.0 T-ScoreStandard Deviation 7.9
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - Pain Interference2-month52.4 T-ScoreStandard Deviation 7.3
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - Pain Interference6-month51.2 T-ScoreStandard Deviation 8
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - Pain Interference12-month50.6 T-ScoreStandard Deviation 7.9
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - Pain InterferenceBaseline59.9 T-ScoreStandard Deviation 5.3
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - Pain InterferenceBaseline60.3 T-ScoreStandard Deviation 5.2
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - Pain Interference2-month53.9 T-ScoreStandard Deviation 7.8
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - Pain Interference6-month52.7 T-ScoreStandard Deviation 8.3
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - Pain Interference12-month52.4 T-ScoreStandard Deviation 8
Secondary

Patient-Reported Outcomes Measurement Information System (PROMIS) - Participation

The PROMIS participation scale consists of 4 questions related to participation in social activities. The raw score is converted to the T-Score that is reported here. The range of possible scores is 27.5 - 64.2. Higher scores indicate greater ability to participate in social activities. A score of 50 represents the average score in a general US reference population and 10 is the standard deviation.

Time frame: Baseline and 2, 6, and 12 months

Population: The Participant Flow tables show counts of completed follow-up defined by completion of the Roland-Morris Disability Questionnaire (RMDQ). There are some participants who completed the RMDQ but not this measure and vice versa. Thus the analysis counts for each time point here may differ somewhat from the Participant Flow tables.

ArmMeasureGroupValue (MEAN)Dispersion
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - ParticipationBaseline46.8 T-ScoreStandard Deviation 6.1
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - Participation2-month53.2 T-ScoreStandard Deviation 7.6
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - Participation6-month54.8 T-ScoreStandard Deviation 7.9
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - Participation12-month55.2 T-ScoreStandard Deviation 8
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - Participation2-month53.5 T-ScoreStandard Deviation 7.4
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - Participation6-month54.5 T-ScoreStandard Deviation 8.5
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - Participation12-month54.7 T-ScoreStandard Deviation 8.4
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - ParticipationBaseline47.7 T-ScoreStandard Deviation 6.7
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - Participation6-month55.0 T-ScoreStandard Deviation 8.7
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - Participation2-month52.9 T-ScoreStandard Deviation 7.7
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - Participation12-month55.8 T-ScoreStandard Deviation 8.4
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - ParticipationBaseline47.7 T-ScoreStandard Deviation 7.2
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - Participation12-month54.1 T-ScoreStandard Deviation 8.5
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - Participation2-month52.1 T-ScoreStandard Deviation 8
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - ParticipationBaseline46.6 T-ScoreStandard Deviation 6
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - Participation6-month53.5 T-ScoreStandard Deviation 8.4
Secondary

Patient-Reported Outcomes Measurement Information System (PROMIS) - Physical Function

The PROMIS physical function scale consists of 4 questions about ability to perform tasks of daily living. The raw score is converted to the T-Score that is reported here. The range of possible scores is 22.6 - 57.0. Higher scores indicate greater physical function. A score of 50 represents the average score in a general US reference population and 10 is the standard deviation.

Time frame: Baseline and 2, 6, and 12 months

Population: The Participant Flow tables show counts of completed follow-up defined by completion of the Roland-Morris Disability Questionnaire (RMDQ). There are some participants who completed the RMDQ but not this measure and vice versa. Thus the analysis counts for each time point here may differ somewhat from the Participant Flow tables.

ArmMeasureGroupValue (MEAN)Dispersion
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - Physical FunctionBaseline40.7 T-ScoreStandard Deviation 4.6
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - Physical Function2-month46.0 T-ScoreStandard Deviation 6.8
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - Physical Function6-month48.0 T-ScoreStandard Deviation 7.5
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - Physical Function12-month48.5 T-ScoreStandard Deviation 7.5
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - Physical Function12-month47.7 T-ScoreStandard Deviation 7.7
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - Physical Function6-month47.3 T-ScoreStandard Deviation 7.4
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - Physical Function2-month46.8 T-ScoreStandard Deviation 7.3
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - Physical FunctionBaseline21.7 T-ScoreStandard Deviation 5.7
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - Physical Function6-month47.5 T-ScoreStandard Deviation 8.1
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - Physical Function12-month48.6 T-ScoreStandard Deviation 7.7
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - Physical Function2-month46.4 T-ScoreStandard Deviation 7
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - Physical FunctionBaseline41.3 T-ScoreStandard Deviation 5.5
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - Physical Function12-month46.6 T-ScoreStandard Deviation 7.4
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - Physical FunctionBaseline40.5 T-ScoreStandard Deviation 4.9
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - Physical Function2-month44.8 T-ScoreStandard Deviation 6.9
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - Physical Function6-month46.3 T-ScoreStandard Deviation 7.6
Secondary

Patient-Reported Outcomes Measurement Information System (PROMIS) - Sleep Disturbance

The PROMIS sleep disturbance scale consists of 4 questions related to sleep disturbance over the past 7 days. The raw score is converted to the T-Score that is reported here. The range of possible scores is 32.0 - 73.3. Higher scores indicate greater sleep disturbance. A score of 50 represents the average score in a general US reference population and 10 is the standard deviation.

Time frame: Baseline and 2, 6, and 12 months

Population: The Participant Flow tables show counts of completed follow-up defined by completion of the Roland-Morris Disability Questionnaire (RMDQ). There are some participants who completed the RMDQ but not this measure and vice versa. Thus the analysis counts for each time point here may differ somewhat from the Participant Flow tables.

ArmMeasureGroupValue (MEAN)Dispersion
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - Sleep Disturbance2-month52.6 T-ScoreStandard Deviation 3.1
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - Sleep DisturbanceBaseline52.0 T-ScoreStandard Deviation 3
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - Sleep Disturbance6-month52.2 T-ScoreStandard Deviation 3.6
Supported Self-Management (SSM)Patient-Reported Outcomes Measurement Information System (PROMIS) - Sleep Disturbance12-month52.2 T-ScoreStandard Deviation 3
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - Sleep Disturbance2-month52.2 T-ScoreStandard Deviation 2.9
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - Sleep Disturbance6-month51.8 T-ScoreStandard Deviation 3.7
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - Sleep DisturbanceBaseline51.8 T-ScoreStandard Deviation 3.4
Spinal Manipulation Therapy (SMT)Patient-Reported Outcomes Measurement Information System (PROMIS) - Sleep Disturbance12-month52.1 T-ScoreStandard Deviation 3.3
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - Sleep Disturbance6-month52.1 T-ScoreStandard Deviation 3.5
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - Sleep Disturbance2-month52.1 T-ScoreStandard Deviation 3.8
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - Sleep Disturbance12-month51.7 T-ScoreStandard Deviation 3.6
Combined SSM/SMTPatient-Reported Outcomes Measurement Information System (PROMIS) - Sleep DisturbanceBaseline52.0 T-ScoreStandard Deviation 3.5
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - Sleep Disturbance12-month51.7 T-ScoreStandard Deviation 3.7
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - Sleep Disturbance2-month52.2 T-ScoreStandard Deviation 3
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - Sleep Disturbance6-month51.9 T-ScoreStandard Deviation 3.4
Medical Care (MC)Patient-Reported Outcomes Measurement Information System (PROMIS) - Sleep DisturbanceBaseline52.1 T-ScoreStandard Deviation 3.1
Secondary

Patient Satisfaction With Treatment

Measured using a 7-point Likert scale: 0 (completely dissatisfied) to 6 (completely satisfied)

Time frame: 6 months

Population: The Participant Flow tables show counts of completed follow-up defined by completion of the Roland-Morris Disability Questionnaire (RMDQ). There are some participants who completed the RMDQ but not this measure and vice versa. Thus the analysis counts for each time point here may differ somewhat from the Participant Flow tables.

ArmMeasureValue (MEAN)Dispersion
Supported Self-Management (SSM)Patient Satisfaction With Treatment4.8 score on a scaleStandard Deviation 1
Spinal Manipulation Therapy (SMT)Patient Satisfaction With Treatment4.8 score on a scaleStandard Deviation 1.1
Combined SSM/SMTPatient Satisfaction With Treatment5.1 score on a scaleStandard Deviation 0.9
Medical Care (MC)Patient Satisfaction With Treatment4.1 score on a scaleStandard Deviation 1.4
Secondary

Patient Satisfaction With Treatment

Measured using a 7-point Likert scale: 0 (completely dissatisfied) to 6 (completely satisfied)

Time frame: 2 months

Population: The counts above are for participants that completed the satisfaction question at the 2-month time point. The Participant Flow tables show counts of completed follow-up defined by completion of the Roland-Morris Disability Questionnaire (RMDQ). There are some participants who completed the RMDQ but not this measure and vice versa. Thus the analysis counts for each time point here may differ somewhat from the Participant Flow tables.

ArmMeasureValue (MEAN)Dispersion
Supported Self-Management (SSM)Patient Satisfaction With Treatment4.9 score on a scaleStandard Deviation 1
Spinal Manipulation Therapy (SMT)Patient Satisfaction With Treatment5.0 score on a scaleStandard Deviation 0.9
Combined SSM/SMTPatient Satisfaction With Treatment5.2 score on a scaleStandard Deviation 0.9
Medical Care (MC)Patient Satisfaction With Treatment4.2 score on a scaleStandard Deviation 1.3
Secondary

Patient Satisfaction With Treatment

Measured using a 7-point Likert scale: 0 (completely dissatisfied) to 6 (completely satisfied)

Time frame: 12 months

Population: The Participant Flow tables show counts of completed follow-up defined by completion of the Roland-Morris Disability Questionnaire (RMDQ). There are some participants who completed the RMDQ but not this measure and vice versa. Thus the analysis counts for each time point here may differ somewhat from the Participant Flow tables.

ArmMeasureValue (MEAN)Dispersion
Supported Self-Management (SSM)Patient Satisfaction With Treatment4.7 score on a scaleStandard Deviation 1.1
Spinal Manipulation Therapy (SMT)Patient Satisfaction With Treatment4.6 score on a scaleStandard Deviation 1.1
Combined SSM/SMTPatient Satisfaction With Treatment5.1 score on a scaleStandard Deviation 1
Medical Care (MC)Patient Satisfaction With Treatment4.0 score on a scaleStandard Deviation 1.4
Secondary

Quebec Task Force

Measured by a blinded examiner who will classify the participant's spinal disorder as 0) no pain; 1) pain without radiation; 2) pain with radiation to the proximal extremity; 3) pain with radiation to the distal extremity; 4) pain with radiation to the extremity and neurologic signs.

Time frame: 2 months

Population: Unlike outcomes collected via surveys, this outcome required an in-person meeting or teleconference. It was frequently difficult to schedule within the outcome window and thus has lower follow-up than survey outcomes.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Supported Self-Management (SSM)Quebec Task Force3: Pain with radiation to extremity, distally8 Participants
Supported Self-Management (SSM)Quebec Task Force1: Pain without radiation150 Participants
Supported Self-Management (SSM)Quebec Task Force4: Pain with radiation to lower limb with neurologic signs1 Participants
Supported Self-Management (SSM)Quebec Task Force2: Pain with radiation to extremity, proximally19 Participants
Supported Self-Management (SSM)Quebec Task Force0: No pain70 Participants
Spinal Manipulation Therapy (SMT)Quebec Task Force2: Pain with radiation to extremity, proximally10 Participants
Spinal Manipulation Therapy (SMT)Quebec Task Force3: Pain with radiation to extremity, distally13 Participants
Spinal Manipulation Therapy (SMT)Quebec Task Force4: Pain with radiation to lower limb with neurologic signs0 Participants
Spinal Manipulation Therapy (SMT)Quebec Task Force1: Pain without radiation106 Participants
Spinal Manipulation Therapy (SMT)Quebec Task Force0: No pain38 Participants
Combined SSM/SMTQuebec Task Force2: Pain with radiation to extremity, proximally11 Participants
Combined SSM/SMTQuebec Task Force0: No pain32 Participants
Combined SSM/SMTQuebec Task Force1: Pain without radiation100 Participants
Combined SSM/SMTQuebec Task Force3: Pain with radiation to extremity, distally10 Participants
Combined SSM/SMTQuebec Task Force4: Pain with radiation to lower limb with neurologic signs2 Participants
Medical Care (MC)Quebec Task Force3: Pain with radiation to extremity, distally13 Participants
Medical Care (MC)Quebec Task Force1: Pain without radiation163 Participants
Medical Care (MC)Quebec Task Force0: No pain59 Participants
Medical Care (MC)Quebec Task Force2: Pain with radiation to extremity, proximally13 Participants
Medical Care (MC)Quebec Task Force4: Pain with radiation to lower limb with neurologic signs5 Participants
Secondary

Recovery From Acute/Sub-acute Low Back Pain

Measured by the proportion of patients with scores of 0 on the 0-10 pain numeric rating scale (NRS) and a score of less than or equal to 2 on the Roland-Morris Disability Questionnaire (RMDQ), a 24-item questionnaire that measures the degree to which a low back problem restricts daily activities.

Time frame: 6 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Supported Self-Management (SSM)Recovery From Acute/Sub-acute Low Back Pain56 Participants
Spinal Manipulation Therapy (SMT)Recovery From Acute/Sub-acute Low Back Pain29 Participants
Combined SSM/SMTRecovery From Acute/Sub-acute Low Back Pain33 Participants
Medical Care (MC)Recovery From Acute/Sub-acute Low Back Pain38 Participants
Secondary

Sit-to-stand

Measured by a blinded examiner, in seconds, the amount of time a person requires to stand up and sit down from a chair 5 times without using their arms

Time frame: 2 months

Population: Unlike outcomes collected via surveys, this outcome required an in-person meeting or teleconference. It was frequently difficult to schedule within the outcome window and thus has lower follow-up than survey outcomes. Measure was not collected in the UG3 phase of the study (November 2018 through April 2019).

ArmMeasureValue (MEAN)Dispersion
Supported Self-Management (SSM)Sit-to-stand10.5 secondsStandard Deviation 2.8
Spinal Manipulation Therapy (SMT)Sit-to-stand11.4 secondsStandard Deviation 3.3
Combined SSM/SMTSit-to-stand10.9 secondsStandard Deviation 2.9
Medical Care (MC)Sit-to-stand10.9 secondsStandard Deviation 3.4
Secondary

STarT Back Risk Classification

The STarT Back Screening Tool is a 9-item questionnaire used to identify prognostic risk factors in patients with low back pain. It assesses physical and psychosocial factors, including referred pain, disability, fear-avoidance, anxiety, and depression. Scores are totaled (0-9) and a psychosocial subscale score (items 5-9, range 0-5) is calculated. Patients are classified as: low risk (total ≤3), medium risk (total ≥4 and psychosocial subscale ≤3), or high risk (total ≥4 and psychosocial subscale ≥4).

Time frame: 2 months

Population: The Participant Flow tables show counts of completed follow-up defined by completion of the Roland-Morris Disability Questionnaire (RMDQ). There are some participants who completed the RMDQ but not this measure and vice versa. Thus the analysis counts may differ somewhat from the Participant Flow tables.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Supported Self-Management (SSM)STarT Back Risk ClassificationHigh risk6 Participants
Supported Self-Management (SSM)STarT Back Risk ClassificationMedium risk45 Participants
Supported Self-Management (SSM)STarT Back Risk ClassificationLow risk238 Participants
Spinal Manipulation Therapy (SMT)STarT Back Risk ClassificationHigh risk2 Participants
Spinal Manipulation Therapy (SMT)STarT Back Risk ClassificationLow risk164 Participants
Spinal Manipulation Therapy (SMT)STarT Back Risk ClassificationMedium risk28 Participants
Combined SSM/SMTSTarT Back Risk ClassificationMedium risk19 Participants
Combined SSM/SMTSTarT Back Risk ClassificationLow risk160 Participants
Combined SSM/SMTSTarT Back Risk ClassificationHigh risk3 Participants
Medical Care (MC)STarT Back Risk ClassificationHigh risk19 Participants
Medical Care (MC)STarT Back Risk ClassificationMedium risk46 Participants
Medical Care (MC)STarT Back Risk ClassificationLow risk226 Participants
Secondary

STarT Back Risk Classification

The STarT Back Screening Tool is a 9-item questionnaire used to identify prognostic risk factors in patients with low back pain. It assesses physical and psychosocial factors, including referred pain, disability, fear-avoidance, anxiety, and depression. Scores are totaled (0-9) and a psychosocial subscale score (items 5-9, range 0-5) is calculated. Patients are classified as: low risk (total ≤3), medium risk (total ≥4 and psychosocial subscale ≤3), or high risk (total ≥4 and psychosocial subscale ≥4).

Time frame: 12 months

Population: The Participant Flow tables show counts of completed follow-up defined by completion of the Roland-Morris Disability Questionnaire (RMDQ). There are some participants who completed the RMDQ but not this measure and vice versa. Thus the analysis counts may differ somewhat from the Participant Flow tables.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Supported Self-Management (SSM)STarT Back Risk ClassificationHigh risk3 Participants
Supported Self-Management (SSM)STarT Back Risk ClassificationMedium risk34 Participants
Supported Self-Management (SSM)STarT Back Risk ClassificationLow risk243 Participants
Spinal Manipulation Therapy (SMT)STarT Back Risk ClassificationMedium risk23 Participants
Spinal Manipulation Therapy (SMT)STarT Back Risk ClassificationLow risk158 Participants
Spinal Manipulation Therapy (SMT)STarT Back Risk ClassificationHigh risk5 Participants
Combined SSM/SMTSTarT Back Risk ClassificationLow risk157 Participants
Combined SSM/SMTSTarT Back Risk ClassificationMedium risk18 Participants
Combined SSM/SMTSTarT Back Risk ClassificationHigh risk3 Participants
Medical Care (MC)STarT Back Risk ClassificationMedium risk39 Participants
Medical Care (MC)STarT Back Risk ClassificationHigh risk14 Participants
Medical Care (MC)STarT Back Risk ClassificationLow risk226 Participants
Secondary

STarT Back Risk Classification

The STarT Back Screening Tool is a 9-item questionnaire used to identify prognostic risk factors in patients with low back pain. It assesses physical and psychosocial factors, including referred pain, disability, fear-avoidance, anxiety, and depression. Scores are totaled (0-9) and a psychosocial subscale score (items 5-9, range 0-5) is calculated. Patients are classified as: low risk (total ≤3), medium risk (total ≥4 and psychosocial subscale ≤3), or high risk (total ≥4 and psychosocial subscale ≥4).

Time frame: 6 months

Population: The Participant Flow tables show counts of completed follow-up defined by completion of the Roland-Morris Disability Questionnaire (RMDQ). There are some participants who completed the RMDQ but not this measure and vice versa. Thus the analysis counts may differ somewhat from the Participant Flow tables.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Supported Self-Management (SSM)STarT Back Risk ClassificationLow risk253 Participants
Supported Self-Management (SSM)STarT Back Risk ClassificationHigh risk5 Participants
Supported Self-Management (SSM)STarT Back Risk ClassificationMedium risk23 Participants
Spinal Manipulation Therapy (SMT)STarT Back Risk ClassificationHigh risk6 Participants
Spinal Manipulation Therapy (SMT)STarT Back Risk ClassificationLow risk156 Participants
Spinal Manipulation Therapy (SMT)STarT Back Risk ClassificationMedium risk24 Participants
Combined SSM/SMTSTarT Back Risk ClassificationMedium risk27 Participants
Combined SSM/SMTSTarT Back Risk ClassificationLow risk147 Participants
Combined SSM/SMTSTarT Back Risk ClassificationHigh risk5 Participants
Medical Care (MC)STarT Back Risk ClassificationLow risk214 Participants
Medical Care (MC)STarT Back Risk ClassificationHigh risk14 Participants
Medical Care (MC)STarT Back Risk ClassificationMedium risk55 Participants
Secondary

The Sock Test

Measured by a blinded examiner on a scale from 0-3, with 0 being can easily grab the toes with the fingertips of both hands and 3 being can hardly, if at all, reach as far as to the malleoli. Each leg is scored separately with the greater leg score serving as the overall score.

Time frame: 2 months

Population: Unlike outcomes collected via surveys, this outcome required an in-person meeting or teleconference. It was frequently difficult to schedule within the outcome window and thus has lower follow-up than survey outcomes.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Supported Self-Management (SSM)The Sock Test0: Patient can easily reach and grab toes with fingertips.112 Participants
Supported Self-Management (SSM)The Sock Test3: Patient has difficulty reaching even the malleoli.77 Participants
Supported Self-Management (SSM)The Sock Test1: Patient can reach toes with effort.28 Participants
Supported Self-Management (SSM)The Sock Test2: Patient can reach beyond the malleoli but cannot reach toes.20 Participants
Spinal Manipulation Therapy (SMT)The Sock Test1: Patient can reach toes with effort.15 Participants
Spinal Manipulation Therapy (SMT)The Sock Test2: Patient can reach beyond the malleoli but cannot reach toes.23 Participants
Spinal Manipulation Therapy (SMT)The Sock Test0: Patient can easily reach and grab toes with fingertips.65 Participants
Spinal Manipulation Therapy (SMT)The Sock Test3: Patient has difficulty reaching even the malleoli.63 Participants
Combined SSM/SMTThe Sock Test0: Patient can easily reach and grab toes with fingertips.53 Participants
Combined SSM/SMTThe Sock Test1: Patient can reach toes with effort.17 Participants
Combined SSM/SMTThe Sock Test2: Patient can reach beyond the malleoli but cannot reach toes.28 Participants
Combined SSM/SMTThe Sock Test3: Patient has difficulty reaching even the malleoli.54 Participants
Medical Care (MC)The Sock Test1: Patient can reach toes with effort.30 Participants
Medical Care (MC)The Sock Test0: Patient can easily reach and grab toes with fingertips.114 Participants
Medical Care (MC)The Sock Test3: Patient has difficulty reaching even the malleoli.75 Participants
Medical Care (MC)The Sock Test2: Patient can reach beyond the malleoli but cannot reach toes.25 Participants
Secondary

Timed Up and Go Test

Measured by a blinded examiner, in seconds, the time taken by a person to stand up, walk a distance of 10 feet, turn, walk back to the chair and sit down again.

Time frame: 2 months

Population: Unlike outcomes collected via surveys, this outcome required an in-person meeting or teleconference. It was frequently difficult to schedule within the outcome window and thus has lower follow-up than survey outcomes.

ArmMeasureValue (MEAN)Dispersion
Supported Self-Management (SSM)Timed Up and Go Test9.5 secondsStandard Deviation 2
Spinal Manipulation Therapy (SMT)Timed Up and Go Test9.5 secondsStandard Deviation 2.3
Combined SSM/SMTTimed Up and Go Test9.5 secondsStandard Deviation 3
Medical Care (MC)Timed Up and Go Test10.0 secondsStandard Deviation 2.2
Secondary

Visual Trajectory for Pain

Assessed using 8 different diagrams describing back pain change over the last 12 months

Time frame: 12 months

Population: The Participant Flow tables show counts of completed follow-up defined by completion of the Roland-Morris Disability Questionnaire (RMDQ). There are some participants who completed the RMDQ but not this measure and vice versa. Thus the analysis counts for each time point here may differ somewhat from the Participant Flow tables.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Supported Self-Management (SSM)Visual Trajectory for Pain(g) Back pain that has improved gradually38 Participants
Supported Self-Management (SSM)Visual Trajectory for Pain(a) A single episode with no other major episode of back pain18 Participants
Supported Self-Management (SSM)Visual Trajectory for Pain(h) No back pain, or only the odd day with mild pain16 Participants
Supported Self-Management (SSM)Visual Trajectory for Pain(e) Severe back pain all or nearly all of the time2 Participants
Supported Self-Management (SSM)Visual Trajectory for Pain(b) A few episodes of back pain, with mostly pain-free periods in between103 Participants
Supported Self-Management (SSM)Visual Trajectory for Pain(c) Some back pain most of the time, and a few episodes of severe pain72 Participants
Supported Self-Management (SSM)Visual Trajectory for Pain(d) Pain that goes up and down all the time, with episodes of severe back pain26 Participants
Supported Self-Management (SSM)Visual Trajectory for Pain(f) Back pain that has got gradually worse2 Participants
Spinal Manipulation Therapy (SMT)Visual Trajectory for Pain(e) Severe back pain all or nearly all of the time2 Participants
Spinal Manipulation Therapy (SMT)Visual Trajectory for Pain(g) Back pain that has improved gradually28 Participants
Spinal Manipulation Therapy (SMT)Visual Trajectory for Pain(b) A few episodes of back pain, with mostly pain-free periods in between53 Participants
Spinal Manipulation Therapy (SMT)Visual Trajectory for Pain(d) Pain that goes up and down all the time, with episodes of severe back pain25 Participants
Spinal Manipulation Therapy (SMT)Visual Trajectory for Pain(f) Back pain that has got gradually worse2 Participants
Spinal Manipulation Therapy (SMT)Visual Trajectory for Pain(h) No back pain, or only the odd day with mild pain12 Participants
Spinal Manipulation Therapy (SMT)Visual Trajectory for Pain(c) Some back pain most of the time, and a few episodes of severe pain58 Participants
Spinal Manipulation Therapy (SMT)Visual Trajectory for Pain(a) A single episode with no other major episode of back pain6 Participants
Combined SSM/SMTVisual Trajectory for Pain(c) Some back pain most of the time, and a few episodes of severe pain56 Participants
Combined SSM/SMTVisual Trajectory for Pain(f) Back pain that has got gradually worse3 Participants
Combined SSM/SMTVisual Trajectory for Pain(b) A few episodes of back pain, with mostly pain-free periods in between51 Participants
Combined SSM/SMTVisual Trajectory for Pain(e) Severe back pain all or nearly all of the time0 Participants
Combined SSM/SMTVisual Trajectory for Pain(a) A single episode with no other major episode of back pain13 Participants
Combined SSM/SMTVisual Trajectory for Pain(g) Back pain that has improved gradually28 Participants
Combined SSM/SMTVisual Trajectory for Pain(d) Pain that goes up and down all the time, with episodes of severe back pain16 Participants
Combined SSM/SMTVisual Trajectory for Pain(h) No back pain, or only the odd day with mild pain11 Participants
Medical Care (MC)Visual Trajectory for Pain(h) No back pain, or only the odd day with mild pain10 Participants
Medical Care (MC)Visual Trajectory for Pain(e) Severe back pain all or nearly all of the time6 Participants
Medical Care (MC)Visual Trajectory for Pain(a) A single episode with no other major episode of back pain15 Participants
Medical Care (MC)Visual Trajectory for Pain(b) A few episodes of back pain, with mostly pain-free periods in between65 Participants
Medical Care (MC)Visual Trajectory for Pain(d) Pain that goes up and down all the time, with episodes of severe back pain51 Participants
Medical Care (MC)Visual Trajectory for Pain(f) Back pain that has got gradually worse3 Participants
Medical Care (MC)Visual Trajectory for Pain(g) Back pain that has improved gradually33 Participants
Medical Care (MC)Visual Trajectory for Pain(c) Some back pain most of the time, and a few episodes of severe pain99 Participants
Other Pre-specified

Catastrophizing

Measured using the 13-item Pain Catastrophizing Scale; it uses a 5-item point scale (0=not at all, 4 all the time). This is a psychosocial mediating measure.

Time frame: Baseline, 2, 6, 12 months

Other Pre-specified

Coping

Measured using an adapted version of the 28-item Brief Coping Orientation to Problems Experienced (COPE) instrument on a 4 point scale (I haven't been doing this at all to I've been doing this a lot). This is a psychosocial mediating measure.

Time frame: Baseline, 2, 6, 12 months

Other Pre-specified

Kinesiophobia

Measured using the 11-item Tampa Scale for Kinesiophobia demonstrated to have internal consistency, responsiveness and validity similar to the original 17-item instrument. A four-item scale is used (strongly disagree to strongly agree). This is a psychosocial mediating measure.

Time frame: Baseline, 2, 6, 12 months

Other Pre-specified

Self-efficacy

Using a 10-100 numerical rating scale (10=very uncertain, 100 = very certain), self-efficacy is measured with the 22-item Chronic Pain Self-Efficacy Scale adapted for acute/sub-acute pain. This is a psychosocial mediating measure.

Time frame: Baseline, 2, 6, 12 months

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026